Abstract:Proc Amer Assoc Cancer Res, Volume 47, 2006 3984 The epithelial components of the mammary gland are thought to arise from stem cells with the capacity for self-renewal and multilineage differentiation. These cells and/or their immediate progeny may be targets for transformation, generating tumors which are driven by cells retaining stem cell properties. We have previously shown that normal mammary stem cell self-renewal is regulated by bi-directional interactions between Hedgehog and Notch pathways with subsequent regulation of the polycomb gene Bmi-1. We have now utilized in vitro suspension based culture systems as well as NOD-SCID mouse models to examine the role of Bmi-1 in regulating human mammary stem cell self-renewal. qRT-PCR demonstrates that Bmi-1 is highly expressed in primitive human mammary cells cultured in mammospheres compared to differentiated cells cultured on collagen substrata. Overexpression of Bmi-1 with a lentivirus vector increases mammosphere initiating cells by 77% and mammosphere size by 61%. In contrast, down regulation of Bmi-1 expression with siRNA lentiviruses reduces mammosphere formation by 80% and mammosphere size by 60%. Inhibiting Bmi-1 expression also abrogates the stimulatory effects of Hedgehog and Notch signaling on mammosphere formation. Modulation of Bmi-1 expression in mammosphere initiating cells altered their mammary gland outgrowth in humanized fat pads of NOD-SCID mice. Interestingly, “tumor stem cells” characterized as CD44+CD24-/lowLin- displayed an 8-fold increase in Bmi-1 expression compared to non-tumorigenic CD44+CD24+Lin- cells isolated from the same human mammary tumor. These studies support a “tumor stem cell model” in which Bmi-1 plays an important role in the self-renewal of both normal and tumorigenic mammary stem cells with disregulation of Bmi-1 promoting carcinogenesis. Since tumor stem cells may drive tumor formation, targeting components of Bmi-1 regulated pathways represents a rationale strategy to eliminate this important cancer cell population.

[Regulatory Effects of Bmi-1 Gene on Self-Renewal of Hematopoietic Stem Cells--review].

Bmi-1, Stem Cells and Cancer

Bmil Gene in Stem Cells and Tumorigenesis

Bmi-1 Regulates Self-Renewal Of Normal And Malignant Human Mammary Stem Cells

Dominant-negative C/ebpα and Polycomb Group Protein Bmi1 Extend Short-Lived Hematopoietic Stem/progenitor Cell Life Span and Induce Lethal Dyserythropoiesis

Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells

Molecular Pathways Regulating the Self-Renewal of Hematopoietic Stem Cells

Bmi-1 determines the stemness of renal stem or progenitor cells

Regulation of Hematopoietic Stem Cells Differentiation, Self-Renewal, and Quiescence Through the Mtor Signaling Pathway

[Effect of Bmi1 Gene Overexpression on Hematopoietic Differentiation Colony-Forming Assay of Human Embryonic Stem Cells].

Bmi-1 Regulates Self-Renewal, Proliferation and Senescence of Human Fetal Neural Stem Cells in Vitro

Bmi-1 high-expressing cells enrich cardiac stem/progenitor cells and respond to heart injury.

BMI-1, a promising therapeutic target for human cancer.

Bmi1 Regulates Mitochondrial Function and the DNA Damage Response Pathway

Bmi-1 Gene is Correlated with the Proliferation and Senescence of Mesenchymal Stem Cells Isolated from Human Fetal Bone Marrow

A Protein Synthesis Brake for Hematopoietic Stem Cell Maintenance.

The Polycomb Group Transcriptional Repressor Bmi-1 is Constitutively Expressed in Multiple Myeloma (MM) Cells and Modulates Proliferation Through a Mechanism Independent of the Ink4a/ARF Locus.

Polycomb group protein Mel18 inhibits hematopoietic stem cell self-renewal through repressing the transcription of self-renewal and proliferation genes

Identification and Characterization of Bmi-1-responding Element within the Human p16 Promoter,

Bmi1 Drives Stem-Like Properties and is Associated with Migration, Invasion, and Poor Prognosis in Tongue Squamous Cell Carcinoma

Mirnas Regulate Stem Cell Self-Renewal and Differentiation